Outlook Therapeutics, Inc. (OTLK)

[H2R]

OTLK hits its planned dates. Again!

I really like the timeline guidance they provide and how they follow up on them. It's been the case for most (all?) of their planned dates. For this one:

Russ mentioned an end of October response from the FDA in his interview.

And here we are, end of October. They don't schmooze, they execute. It raises the level of trust in the Company.

Best of luck with your investments!